An Open, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration (wAMD) — LAMP  

Very Low Vision Secondary to Wet Age-related Macular Degeneration Clinical Trial

Official title: An Open, Non-randomize, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration

Status Active, not recruiting

Clinical Trial Summary

This study is designed to evaluate the effect of Conbercept therapy on visual acuity and anatomic outcomes and safety observed in subjects with very low vision secondary to wet age-related macular degeneration.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Macular Degeneration
• Neoplasm Metastasis
• Very Low Vision Secondary to Wet Age-related Macular Degeneration
• Vision, Low

• NCT number: NCT02098720
• Study type: Interventional
• Source: Chengdu Kanghong Biotech Co.,Ltd.
• Status: Active, not recruiting
• Phase: Phase 2
• Start date: December 2011